相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Why Most Acute Stroke Studies Are Positive in Animals but Not in Patients: A Systematic Comparison of Preclinical, Early Phase, and Phase 3 Clinical Trials of Neuroprotective Agents
Antje Schmidt-Pogoda et al.
ANNALS OF NEUROLOGY (2020)
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease A Randomized Clinical Trial
Robert Howard et al.
JAMA NEUROLOGY (2020)
Advances in oral immunomodulating therapies in relapsing multiple sclerosis
Tobias Derfuss et al.
LANCET NEUROLOGY (2020)
Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model
Congcong Sun et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies
Milky Kohno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
N. Cakici et al.
PSYCHOLOGICAL MEDICINE (2019)
The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia
Lulu Zhang et al.
SCHIZOPHRENIA RESEARCH (2019)
Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients
Caroline A. Arout et al.
PSYCHOPHARMACOLOGY (2019)
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
Mark Weiser et al.
SCHIZOPHRENIA RESEARCH (2019)
Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials
Joshua D. Rosenblat et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo
James W. Murrough et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia
Fang Liu et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats
Ya-Lin Wang et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
Alexander E. Volk et al.
MEDIZINISCHE GENETIK (2018)
Chronic minocycline treatment improves hippocampal neuronal structure, NMDA receptor function, and memory processing in Fmr1 knockout mice
S. Y. Yau et al.
NEUROBIOLOGY OF DISEASE (2018)
Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels
Lulu Zhang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2x2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
Jonathan B. Savitz et al.
TRANSLATIONAL PSYCHIATRY (2018)
Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation
Hai-Yan Liu et al.
BRAIN RESEARCH BULLETIN (2018)
Environmental enrichment reduces adolescent anxiety- and depression-like behaviors of rats subjected to infant nerve injury
Xingrui Gong et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia
Fang Liu et al.
SCHIZOPHRENIA RESEARCH (2018)
Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
Jung Won Kim et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2018)
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
Bill Deakin et al.
LANCET PSYCHIATRY (2018)
What role does multiple sclerosis play in the development of untreatable painful conditions?
Stefania Ceruti
PAIN MANAGEMENT (2018)
Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
Muhammad Husain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson's Disease
Aileen Cronin et al.
NEUROSCIENCE (2017)
Early-Life Social Isolation-Induced Depressive-Like Behavior in Rats Results in Microglial Activation and Neuronal Histone Methylation that Are Mitigated by Minocycline
Hong-Tao Wang et al.
NEUROTOXICITY RESEARCH (2017)
Minocycline protects, rescues and prevents knockdown transgenic parkin Drosophila against paraquat/iron toxicity: Implications for autosomic recessive juvenile parkinsonism
Hector Flavio Ortega-Arellano et al.
NEUROTOXICOLOGY (2017)
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
L. M. Metz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice
Michelle Lima Garcez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
Olivia M. Dean et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Minocycline Attenuates Depressive-Like Behaviour Induced by Rat Model of Testicular Torsion: Involvement of Nitric Oxide Pathway
Seyed Soheil Saeedi Saravi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system
Seyed Soheil Saeedi Saravi et al.
METABOLIC BRAIN DISEASE (2016)
Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions
Vinod Kumar et al.
MOLECULAR NEUROBIOLOGY (2016)
Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice
Jafar Majidi et al.
BRAIN RESEARCH BULLETIN (2016)
Administration of the glial cell modulator, minocycline, in the nucleus accumbens attenuated the maintenance and reinstatement of morphine-seeking behavior
Reza Arezoomandan et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial
Hamid Emadi-Kouchak et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2016)
Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
Ali Ghaleiha et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2016)
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial
Sophia Esalatmanesh et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2016)
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
Deanna L. Kelly et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Minocycline enhances hippocampal memory, neuroplasticity and synapse-associated proteins in aged C57 BL/6 mice
Ying Jiang et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2015)
INFLAMMATION IS GENETICALLY IMPLICATED IN PARKINSON'S DISEASE
N. Dzamko et al.
NEUROSCIENCE (2015)
THE RELATION BETWEEN α-SYNUCLEIN AND MICROGLIA IN PARKINSON'S DISEASE: RECENT DEVELOPMENTS
V. Sanchez-Guajardo et al.
NEUROSCIENCE (2015)
Minocycline attenuates Aβ oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Aβ fibrils phagocytosis
Ismail Amr El-Shimy et al.
NEUROSCIENCE LETTERS (2015)
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia
Cristiano Chaves et al.
SCHIZOPHRENIA RESEARCH (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression
Nikita N. Burke et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment
Kae M. Pusic et al.
GLIA (2014)
The Neuroprotection Exerted by Memantine, Minocycline and Lithium, against Neurotoxicity of CSF from Patients with Amyotrophic Lateral Sclerosis, Is Antagonized by Riluzole
Matilde Yanez et al.
NEURODEGENERATIVE DISEASES (2014)
Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat
Ghassem Attarzadeh-Yazdi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Saeid Ghavami et al.
PROGRESS IN NEUROBIOLOGY (2014)
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study
Mohammad-Reza Khodaie-Ardakani et al.
PSYCHIATRY RESEARCH (2014)
Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
Fang Liu et al.
SCHIZOPHRENIA RESEARCH (2014)
Minocycline as Add-On Treatment Decreases the Negative Symptoms of Schizophrenia; A Randomized Placebo-Controlled Clinical Trial
Ahmad Ghanizadeh et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2014)
Profile of minocycline and its potential in the treatment of schizophrenia
Lulu Zhang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
High MMP-9 Activity Levels in Fragile X Syndrome are Lowered by Minocycline
Magdalena Dziembowska et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease
Anubhuti Dixit et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Minocycline: far beyond an antibiotic
N. Garrido-Mesa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: Behavioral, biochemical, cellular and histological evidences
Anil Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
Mary Jacena S. Leigh et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2013)
A review of anti-inflammatory agents for symptoms of schizophrenia
William R. Keller et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
LONG-LASTING EFFECTS OF MINOCYCLINE ON BEHAVIOR IN YOUNG BUT NOT ADULT FRAGILE X MICE
L. E. Dansie et al.
NEUROSCIENCE (2013)
What is behind the non-antibiotic properties of minocycline?
N. Garrido-Mesa et al.
PHARMACOLOGICAL RESEARCH (2013)
Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis
Chaoyun Li et al.
REVIEWS IN THE NEUROSCIENCES (2013)
A pilot open-label trial of minocycline in patients with autism and regressive features
Carlos A. Pardo et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2013)
Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines
Andrew S. C. Rice et al.
SCANDINAVIAN JOURNAL OF PAIN (2013)
Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome
Sarah E. Rotschafer et al.
BRAIN RESEARCH (2012)
Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis
Xiaohong Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology
Maria Teresa Ferretti et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Minocycline Effects on the Cerebrospinal Fluid Proteome of Experimental Autoimmune Encephalomyelitis Rats
Marcel P. Stoop et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
Imran B. Chaudhry et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer's Disease
Barbara Biscaro et al.
NEURODEGENERATIVE DISEASES (2012)
Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington's Disease-Like Symptoms in Rats
Harikesh Kalonia et al.
NEUROTOXICITY RESEARCH (2012)
The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice
Yuko Fujita et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline
Shiho Arakawa et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
Tsuyoshi Miyaoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Matrix Metalloproteinases andMinocycline: Therapeutic Avenues for Fragile X Syndrome
Saul S. Siller et al.
NEURAL PLASTICITY (2012)
Minocycline reduces ethanol drinking
R. G. Agrawal et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase
Saul S. Siller et al.
DISEASE MODELS & MECHANISMS (2011)
Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans
Mehmet Sofuoglu et al.
PSYCHOPHARMACOLOGY (2011)
Open-label add-on treatment trial of minocycline in fragile X syndrome
Carlo Paribello et al.
BMC NEUROLOGY (2010)
Minocycline Protects Dopaminergic Neurons Against Long-Term Rotenone Toxicity
Khaled Radad et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2010)
Reductions in Amyloid-beta-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation
Anna Parachikova et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
Yechiel Levkovitz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder: An Open-Label Trial
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Minocycline 1-Year Therapy in Multiple-System-Atrophy: Effect on Clinical Symptoms and [11C] (R)-PK11195 PET (MEMSA-Trial)
Richard Dodel et al.
MOVEMENT DISORDERS (2010)
A Futility Study of Minocycline in Huntington's Disease
Heidi Schwarz et al.
MOVEMENT DISORDERS (2010)
MRS study of the effects of minocycline on markers of neuronal and microglial integrity in ALS
Abdesslem Khiat et al.
MAGNETIC RESONANCE IMAGING (2010)
Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease
Katharina Faust et al.
BMC NEUROSCIENCE (2009)
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease
Wendy Noble et al.
FASEB JOURNAL (2009)
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice
Xiaohong Chen et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
L. M. Metz et al.
MULTIPLE SCLEROSIS (2009)
Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans
Mehmet Sofuoglu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
T. V. Bilousova et al.
JOURNAL OF MEDICAL GENETICS (2009)
Pilot study of minocycline in relapsing-remitting multiple sclerosis
Yunyan Zhang et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2008)
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results
Karl Kieburtz et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Tsuyoshi Miyaoka et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Minocycline for patients with ALS
Maria Teresa Carri
LANCET NEUROLOGY (2008)
Minocycline for patients with ALS
Peter N. Leigh et al.
LANCET NEUROLOGY (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
Yuko Fujita et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Antidepressant-like actions of minocycline combined with several glutamate antagonists
Miguel Molina-Hernandez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's Disease models
Yoori Choi et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine
Lin Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia
Yechiel Levkovitz et al.
BRAIN RESEARCH (2007)
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)α/βII
Maria Nikodemova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study
R. K. Zabad et al.
MULTIPLE SCLEROSIS (2007)
Lack of minocycline efficiency in genetic models of Huntington's disease
Stephane Mievis et al.
NEUROMOLECULAR MEDICINE (2007)
Possible antipsychotic effects of minocycline in patients with schizophrenia
Tsuyoshi Miyaoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Revisiting safety of minocycline as neuroprotection in Huntington's disease
Norman Reynolds
MOVEMENT DISORDERS (2007)
Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration
Jun Peng et al.
JOURNAL OF NEUROSCIENCE (2006)
Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease
Elias Matthew Quintero et al.
BRAIN RESEARCH (2006)
Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice
TJ Seabrook et al.
GLIA (2006)
Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
MJ Casarejos et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
EC Stack et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity:: role of tumor necrosis factor-α
K Sriram et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
A Familian et al.
GLIA (2006)
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease
J. K. Ryu et al.
NEUROSCIENCE (2006)
Minocycline in amyotrophic lateral sclerosis: a pilot study
FE Pontieri et al.
NEUROLOGICAL SCIENCES (2005)
Effective combination of minocycline and interferon-β in a model of multiple sclerosis
F Giuliani et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide
T Deak et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Minocycline in phenotypic models of Huntington's disease
K Bantubungi et al.
NEUROBIOLOGY OF DISEASE (2005)
Additive effect of the combination of glatiramer acetate and minocycline in a model of MS
F Giuliani et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Neuroprotection in Huntingtons disease:: a 2-year study on minocycline
RM Bonelli et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Minocycline in Huntington's disease: A pilot study
M Thomas et al.
MOVEMENT DISORDERS (2004)
Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system
M Tomás-Camardiel et al.
NEUROBIOLOGY OF DISEASE (2004)
Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning
CL Hunter et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
E Diguet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
PH Gordon et al.
NEUROLOGY (2004)
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis
LM Metz et al.
ANNALS OF NEUROLOGY (2004)
Minocycline enhances MPTP toxicity to dopaminergic neurons
LC Yang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
X Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Minocycline and doxycycline are not beneficial in a model of Huntington's disease
DL Smith et al.
ANNALS OF NEUROLOGY (2003)
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS
WH Zhang et al.
ANNALS OF NEUROLOGY (2003)
Maintained improvement with minocycline of a patient with advanced Huntington's disease
EM Denovan-Wright et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Effect a minocycline in experimental autoimmune encephalomyelitis
S Nessler et al.
ANNALS OF NEUROLOGY (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Targeting leukocyte MMPs and transmigration - Minocycline as a potential therapy for multiple sclerosis
V Brundula et al.
BRAIN (2002)
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
S Zhu et al.
NATURE (2002)
Inhibition of autoimmune encephalomyelitis by a tetracycline
N Popovic et al.
ANNALS OF NEUROLOGY (2002)
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease
DC Wu et al.
JOURNAL OF NEUROSCIENCE (2002)
Toward a neurobiology of obsessive-compulsive disorder
AM Graybiel et al.
NEURON (2000)
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
M Chen et al.
NATURE MEDICINE (2000)
分享论文
